Data / Form D filings / MANHATTAN PHARMACEUTICALS INC
MANHATTAN PHARMACEUTICALS INC: Form D filings
MANHATTAN PHARMACEUTICALS INC, a pharmaceuticals company in New York, NY, filed 4 Form D notices with the SEC between 2010 and 2012. The latest, on March 26, 2012, reports $11.1 million sold of a $25 million offering.
Find out what MANHATTAN PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 787 SEVENTH AVENUE, 48TH FLOOR, SUITE100, New York, NY, 10019
- Phone
- (212) 554-4505
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1001316
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 26, 2012 | New notice | $25,000,000 | $11,091,426 | $13,908,574 | 0 | Dec 30, 2011 | sec.gov |
| Feb 29, 2012 | Amendment | $25,000,000 | $25,000,000 | $0 | 416 | Dec 30, 2011 | sec.gov |
| Feb 22, 2012 | Amendment | $25,000,000 | $20,875,405 | $4,124,595 | 327 | Dec 30, 2011 | sec.gov |
| Mar 16, 2010 | New notice | $4,000,000 | $2,547,500 | $1,452,500 | 77 | Mar 2, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| MICHAEL WEISS | Executive Officer, Director | |
| SEAN POWER | Executive Officer | |
| NEIL HERSKOWITZ | Director |
Other pharmaceuticals companies in New York that filed recently
- NBO Pharma Inc. $238,000 · Nov 9, 2026
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Mar 26, 2012 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what MANHATTAN PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.